Impact of Landmark Responses on 3-Year Outcomes in CP-CML Patients in the Ponatinib PACE Trial
Talpaz, Moshe, Müller, Martin, Baccarani, Michele, Deininger, Michael, Guilhot, François, Hochhaus, Andreas, Hughes, Timothy, Shah, Neil, Lustgarten, Stephanie, Rivera, Victor, Clackson, Tim, Haluska,Volume:
16
Language:
english
Journal:
Clinical Lymphoma Myeloma and Leukemia
DOI:
10.1016/j.clml.2016.07.089
Date:
September, 2016
File:
PDF, 159 KB
english, 2016